FRIERI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.132
EU - Europa 2.782
AS - Asia 2.464
SA - Sud America 275
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 20
OC - Oceania 7
AN - Antartide 1
Totale 10.791
Nazione #
US - Stati Uniti d'America 5.008
SG - Singapore 968
IE - Irlanda 581
CN - Cina 574
RU - Federazione Russa 485
IT - Italia 449
SE - Svezia 310
TR - Turchia 281
HK - Hong Kong 251
DE - Germania 241
BR - Brasile 230
VN - Vietnam 226
GB - Regno Unito 208
UA - Ucraina 163
FR - Francia 128
FI - Finlandia 97
CA - Canada 64
IN - India 33
JP - Giappone 28
BD - Bangladesh 25
MX - Messico 22
BE - Belgio 21
CZ - Repubblica Ceca 21
AR - Argentina 19
NL - Olanda 18
PL - Polonia 16
ES - Italia 14
IQ - Iraq 13
ID - Indonesia 12
CO - Colombia 10
CR - Costa Rica 8
HN - Honduras 8
AU - Australia 6
EC - Ecuador 6
EU - Europa 6
RO - Romania 6
UZ - Uzbekistan 6
LT - Lituania 5
SV - El Salvador 5
ZA - Sudafrica 5
IL - Israele 4
KR - Corea 4
PH - Filippine 4
SA - Arabia Saudita 4
VE - Venezuela 4
AZ - Azerbaigian 3
CG - Congo 3
EE - Estonia 3
JO - Giordania 3
KW - Kuwait 3
LU - Lussemburgo 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
PK - Pakistan 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BZ - Belize 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
PY - Paraguay 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
ML - Mali 1
MT - Malta 1
NZ - Nuova Zelanda 1
OM - Oman 1
SC - Seychelles 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
Totale 10.687
Città #
Jacksonville 647
Chandler 614
Dublin 581
Singapore 577
San Jose 516
Ashburn 345
Dallas 275
Council Bluffs 257
Hong Kong 249
Santa Clara 213
Boardman 191
Izmir 135
Nanjing 135
New York 123
Ann Arbor 110
San Mateo 108
The Dalles 87
Beijing 85
Lawrence 85
Milan 85
Princeton 84
Moscow 80
Ho Chi Minh City 78
Wilmington 73
Lauterbourg 54
Hanoi 52
Los Angeles 49
Rome 40
Woodbridge 40
L'aquila 33
São Paulo 32
Dearborn 31
Nanchang 31
Hefei 28
Verona 28
Munich 27
Des Moines 25
Shanghai 24
Shenyang 23
Tokyo 23
Seattle 22
Brussels 21
Kunming 21
Montreal 21
Tianjin 21
Bremen 20
Orem 20
Brno 18
Hebei 18
London 18
Jiaxing 17
Jinan 16
Norwalk 16
Warsaw 16
Frankfurt am Main 15
Turku 14
Mexico City 13
Miano 13
Mountain View 13
Stockholm 13
Columbus 12
Dong Ket 12
Helsinki 12
L’Aquila 12
Turin 12
Atlanta 11
Boston 11
Changsha 11
Ningbo 11
Toronto 11
Amsterdam 10
Chennai 10
Florence 10
Naples 10
Poplar 10
Brooklyn 9
Chicago 9
Da Nang 9
Hangzhou 9
Las Vegas 9
Phoenix 8
Rio de Janeiro 8
Auburn Hills 7
Brasília 7
Manchester 7
Philadelphia 7
Ankara 6
Buffalo 6
Falls Church 6
Houston 6
North Bergen 6
San Francisco 6
San José 6
Tappahannock 6
Zhengzhou 6
Berlin 5
Dhaka 5
Falkenstein 5
Guangzhou 5
Haiphong 5
Totale 6.952
Nome #
Association between vasomotor rhinitis and irritable bowel syndrome. 246
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 187
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 183
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 174
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? 170
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 169
IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature 169
Histological healing in ulcerative colitis with mesalazine and its prognostic role 168
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 166
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 163
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 160
GI distension in severe ulcerative colitis 157
Association between colonic diverticula and colorectal polyps and cancer 156
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 154
Association between colorectal polyps and colonic diverticulosis 151
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 147
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 145
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 143
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 142
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 138
Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-β1 downregulation 137
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 136
Il 5-ASA (Asacol) previene le recidive post-operatorie del morbo di Crohn. Risultati dello studio GISC a tre anni di follow-up. 135
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 135
Duodenal lymphocytosis in functional dyspepsia 135
Celiac disease, gluten-free diet, and metabolic and liver disorders 135
Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats 134
Is mesalazine treatment effective in the prevention of diverticulitis? A review 134
Ulcerative Colitis: rectal dilations in a patient with refractory diarrhoea. Report of a case 130
Electrolyte and acid base imbalance in patients with rectosigmoid bladder. 130
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 129
Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity 129
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients 128
Early acid perception in NERD 128
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 128
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 128
Mucosal healing: Mayo 0 vs 1 after 3 years. 127
Acute colitis following colonoscopy 126
Dextran sulfate sodium (DSS) colitis in rats. Clinical, structural, and ultrastructual aspects 126
Short-chain fatty acids topical treatment in distal ulcerative colitis 123
Colonic electromyography in chronic constipation. 123
Prognostic factors for post-operative recurrence of Crohn's disease 122
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010 121
Colonoscopic control of uretero-enteric anastomoses in internal urinary diversion. 119
Carbonic andhydrase I reduction in colonic mucosa of patients with active ulcerative colitis 119
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 119
Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis Randomized, Double-Blind, Placebo-Controlled Pilot Study 118
n-Butyrate Rectal Transport in Cirrhotic Patients 118
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 117
Assesment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhancement MRI 117
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease 117
Incidence of inflammatory Bowel disease in Italy: A nationwide population-based study 115
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis 115
An unusual treatment for a colonic polyp. 114
The role on endoscopy in alcohol-related diseases 114
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's Patients 113
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine 112
Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet. 112
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 112
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis. 110
Multiple organ dysfunction in ulcerative colitis 108
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 108
Italian consensus guidelines for chronic pancreatitis. 105
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 104
Management of colonic diverticular disease. 104
Historical evolution of the management of severe ulcerative colitis 104
Current opinions on treatment of inflammatory bowel disease 104
Abnormal Patterns of Colorectal Mucin Secretion after Urinary Diversion of Different Types: Histochemical and Lectin Binding Studies 104
Mesalazine vanishing time from rectal mucosa following its topical administration. 103
Abnormalities of colonic mucin secretion and metabolic changes after internal urinary diversion for bladder extrophy. A prospective study. 103
Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic biopsy samples in humans by high-performance liquid chromatography with electrochemical detection 103
The long journey of salicylates in ulcerative colitis: The past and the future. 102
Consequence of colonic involvement on electrolyte and acid-base homeostasis in crohn's disease 102
Abnormal Patterns of Colonic Mucin Secretion after Ureterosigmoidostomy 102
Report of the 3rd National Congress of the Italian Federation of Coloproctology. 102
CROHN’S DISEASE ACTIVITY INDEX IS INACCURATE TO DETECT THE POSTOPERATIVE RECURRENVCE IN CROHN’S DISEASE 100
Faecal excretion of bicarbonate in ulcerative colitis 100
Mucosal 5-ASA concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis 100
Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick? 97
Gastrointestinal: Eosinophilic ascites. 97
Risk factors in toxic megacolon 94
Meccanismi e approccio alla fisiopatologia della diarrea. 91
Genetic analysis in italian families with inflammatory bowel disease supports linkage to the IBD1 locus-a GISC study 85
Fattori di rischio per la recidiva post-operatoria nel morbo di Crohn. 84
The dyspeptic macrophage 30 years later. An update in the pathogenesis of Crohn's disease 82
Thecnical performance of colonoscopy: thekey role of sedation/analgesia and other quality indicators 75
Totale 10.791
Categoria #
all - tutte 44.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022351 0 0 0 44 23 4 10 31 25 28 37 149
2022/20231.714 116 97 30 197 152 186 0 116 740 7 47 26
2023/2024390 56 22 17 60 27 112 21 18 0 9 5 43
2024/20251.495 18 25 145 36 150 130 228 163 344 70 104 82
2025/20263.055 125 260 176 383 320 235 587 114 236 347 220 52
2026/2027972 77 121 246 528 0 0 0 0 0 0 0 0
Totale 10.791